GE awarded HealthTrust purchasing deal

By staff writers

April 6, 2017 -- GE Healthcare will provide SPECT and PET radiopharmaceuticals to members of the HealthTrust group purchasing organization across the U.S.

The agreement went into effect on March 1 and covers approximately 1,600 acute-care facilities and HealthTrust members in more than 26,000 locations, including ambulatory surgery centers, physician practices, and long-term and alternate care sites.

HealthTrust member facilities will have access to GE Life Sciences' SPECT proprietary products such as Myoview and Ceretec, as well as non-GE Healthcare products such as methylene diphosphonate (MDP), indium-111, and thallium chloride.

Copyright © 2017

To read this and get access to all of the exclusive content on create a free account or sign-in now.

Member Sign In:
MemberID or Email Address:  
Do you have a password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?
Sign in using your social networking account:
Sign in using your social networking